Drug Shortage Report for CONSTELLA

Last updated on 2022-07-10 History
Report ID 162248
Drug Identification Number 02417170
Brand name CONSTELLA
Common or Proper name linaclotide capsules
Company Name ALLERGAN INC
Market Status MARKETED
Active Ingredient(s) LINACLOTIDE
Strength(s) 290MCG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 30s
ATC code A06AX
ATC description DRUGS FOR CONSTIPATION
Reason for shortage Demand increase for the drug.
Anticipated start date 2022-06-09
Actual start date
Estimated end date 2022-07-08
Actual end date 2022-07-08
Shortage status Resolved
Updated date 2022-07-10
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2022-07-10 French Compare
v4 2022-07-10 English Compare
v3 2022-06-10 English Compare
v2 2022-06-09 French Compare
v1 2022-06-09 English Compare

Showing 1 to 5 of 5